Arrowhead Pharmaceuticals Inc (NAS:ARWR)
$ 25.5 1.71 (7.19%) Market Cap: 3.17 Bil Enterprise Value: 2.76 Bil PE Ratio: 0 PB Ratio: 6.54 GF Score: 54/100

Arrowhead Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 03:40PM GMT
Release Date Price: $19.17 (+3.06%)
Unidentified Analyst

Thank you so much for coming today for the Bank of America Healthcare Conference in Vegas. My name is [Chan Wong] and I'm on the large-cap biotech team from [Yin Kwong]. So today, it's my pleasure to have Dr. Chris Anzalone, the President and CEO from Arrowhead. So thank you for coming.

Christopher R. Anzalone
Arrowhead Pharmaceuticals, Inc. - CEO, President & Director

Thank you very much for having us. It's great to be here.

Unidentified Analyst

Yes. Hopefully, you're enjoying the conference so far.

Christopher R. Anzalone
Arrowhead Pharmaceuticals, Inc. - CEO, President & Director

Yes.

Unidentified Analyst

Maybe we just start the Q&A now.

Questions & Answers

Unidentified Analyst;

So you guys have made a lot of progress for the last 1.5 years. Would you mind -- just give us like overall views where your programs are, that will be helpful for our view here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot